Washington, Oct 24 : A systematic review of nine studies has shown that women undergoing in vitro fertilization (IVF) cannot rely upon low-dose aspirin to increase their chances of having a successful pregnancy.

Earlier studies have shown that aspirin therapy improves pregnancy rates for women undergoing IVF, while others have indicated that it increases the risk of miscarriage.

“It is thought by some that taking low-dose aspirin may improve blood flow to the uterus and therefore improve ovarian response to IVF treatment, so it may be of benefit to women who have previously responded poorly to IVF treatment,” said the review’s lead author Vanessa Poustie, Ph.D., at the Institute for Child Health at the University of Liverpool in England.

Washington, October 24 : Surgeons at the Ohio State University Medical Center have preformed the first incisionless surgery in the US by using a device known as EsophyX, approved by the Food and Drug Administration, to cure gastroesophageal reflux disease (GERD), also known as heartburn.

The surgeons have treated the first two patients in the country by using the device.

The mechanism, which is new in the US, has been proven safe and effective in patients treated throughout Europe for GERD.

According to the surgeons, the new procedure does not leave any scars and results in minimal post-operative pain. It also reduces patients’ recovery time significantly, they say.

Washington, Oct 24 : A Harvard study has found that people with schizophrenia are more likely to die of heart disease than other people.

The study has found that schizophrenics are less likely to receive good preventive care for their heart problems, in large part because they are more likely to see a psychiatrist than a primary care physician or cardiologist putting more burden for assessing and monitoring heart health on the mental health team or on patients and families.

The other important factor for hindering the preventive care is medication non-compliance.

The research points out that at least half of people with schizophrenia would stop taking antipsychotic medication at some point, so clinicians might assume that compliance with other medications would also be poor.

Washington, October 24 : A pre-clinical study by biopharmaceutical company Orexigen Therapeutics

Washington, Oct 24 : The reason behind obesity is not just limited to poor eating habits a

Washington, Oct 24 : Ever wondered why dark rooms are so scary and dim corners make your h